Literature DB >> 13405048

Introduction of marked as well as prolonged biologic activity by esterification; 17-alpha-hydroxyprogesterone caproate, a unique progestational compound.

E C REIFENSTEIN.   

Abstract

Entities:  

Keywords:  ESTRUS CYCLE/effect of drugs on; PROGESTERONE/related compounds

Mesh：

Substances：

Year:  1957        PMID： 13405048     DOI： 10.1016/s0015-0282(16)32585-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  3 in total

1.  Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins.

Authors:  Barbara J Attardi; Anthony Zeleznik; Hyagriv Simhan; Jye Ping Chiao; Donald R Mattison; Steve N Caritis
Journal:  Am J Obstet Gynecol       Date:  2007-12       Impact factor: 8.661

2.  Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.

Authors:  Steve N Caritis; Dwight J Rouse; Alan M Peaceman; Anthony Sciscione; Valerija Momirova; Catherine Y Spong; Jay D Iams; Ronald J Wapner; Michael Varner; Marshall Carpenter; Julie Lo; John Thorp; Brian M Mercer; Yoram Sorokin; Margaret Harper; Susan Ramin; Garland Anderson
Journal:  Obstet Gynecol       Date:  2009-02       Impact factor: 7.661

3.  The effect of esterases on 17alpha-hydroxyprogesterone caproate.

Authors:  Ru Yan; Valentina Fokina; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Am J Obstet Gynecol       Date:  2007-10-22       Impact factor: 8.661
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.